CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Focus Partners Wealth

Focus Partners Wealth lowered its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 19.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 368,097 shares of the pharmacy operator's stock after selling 89,017 shares during the period. Focus Partners Wealth's holdings in CVS Health were worth $16,570,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Whitebox Advisors LLC acquired a new stake in CVS Health during the 4th quarter valued at $249,000. Hall Laurie J Trustee grew its holdings in CVS Health by 25,484.4% during the 4th quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator's stock valued at $517,000 after purchasing an additional 11,468 shares in the last quarter. B&D White Capital Company LLC acquired a new stake in CVS Health during the 4th quarter valued at $417,000. Fairfax Financial Holdings Ltd. Can acquired a new stake in CVS Health during the 4th quarter valued at $121,742,000. Finally, Seizert Capital Partners LLC grew its holdings in CVS Health by 22.8% during the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after purchasing an additional 105,708 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Ratings Changes

CVS has been the subject of a number of recent analyst reports. Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and raised their price target for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Truist Financial increased their price objective on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday. UBS Group increased their price objective on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Piper Sandler increased their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Finally, Argus set a $77.00 price objective on shares of CVS Health in a research note on Tuesday, February 18th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $74.94.

CVS Health Stock Performance

Shares of CVS Health stock traded up $2.04 during trading hours on Friday, reaching $62.51. The company's stock had a trading volume of 10,777,559 shares, compared to its average volume of 11,445,306. The company's 50 day simple moving average is $66.62 and its 200 day simple moving average is $59.16. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The stock has a market cap of $79.07 billion, a P/E ratio of 17.08, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same quarter last year, the company earned $1.31 EPS. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.26%. CVS Health's payout ratio is 63.48%.

Insider Buying and Selling at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael F. Mahoney bought 30,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. This represents a 320.65% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.22% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.